Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Children's cancers, Children's neuroblastoma
Closed
Phase 1
This study is looking at combining mIBG, nivolumab and dinutuximab beta to treat neuroblastoma that has continued to grow during treatment or came back after treatment.
This study is mainly for children and young people. We use the term 'you' in this summary, but if you are a parent, we are referring to your child.
Recruitment start: 1 July 2018
Recruitment end: 29 October 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Juliet Gray
Bristol-Myers Squibb
Eusa Pharma
Experimental Cancer Medicine Centre (ECMC)
Joining Against Cancer in Kids (J-A-C-K)
Solving Kids Cancer (SKC)
University Hospital Southampton NHS Foundation Trust
Last reviewed: 29 October 2024
CRUK internal database number: 15887
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
